0001415889-24-012917.txt : 20240510 0001415889-24-012917.hdr.sgml : 20240510 20240510181052 ACCESSION NUMBER: 0001415889-24-012917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240508 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Connor Donal CENTRAL INDEX KEY: 0001625377 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 24936379 MAIL ADDRESS: STREET 1: C/O PERRIGO COMPANY PLC STREET 2: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-05102024_100546.xml X0508 4 2024-05-08 0001583107 Theravance Biopharma, Inc. TBPH 0001625377 O'Connor Donal C/O THERAVANCE BIOPHARMA US, INC 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 true false false false 0 Ordinary Shares 2024-05-08 4 A 0 10537 0 A 63555 D Share Option (Right to Buy) 9.49 2024-05-08 4 A 0 23576 0 A 2034-05-07 Ordinary Shares 23576 23576 D This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. /s/ Brett A. Grimaud, Attorney-in-Fact 2024-05-10